“… - Participants: representatives of AIOM and Fondazione AIOM, institutional and governmental stakeholders, HCPs involved in the care of patients with cancer (medical oncologists, surgeons, general practitioners, psycho-oncologists, nurses), jurists, philosophers, theologians, journalists, LGBTQIA + communities such as the Italian association of LGBTQIA + medical care providers (AMIGAY), and the Association for transgender culture and ethics (ACET), patients and their representatives, and representatives of other scientific societies.
- Topics: based on the data presented in our previous narrative review 7 and national surveys, 8 ten macro-areas were identified and further explored during the discussions that took place over the course of the two working days. The topics covered included: gender identity data collection, clinical trial inclusion, creation of inclusive environments, screening, coordination between gender affirming care and cancer treatments, psychological dimensions of cancer care, HCPs training, primary prevention education for transgender and gender-diverse youth, the social-economic drivers of marginalization, collaboration with LGBTQIA + associations.
…”